These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 18315558)
1. Proteasomes remain intact, but show early focal alteration in their composition in a mouse model of amyotrophic lateral sclerosis. Kabashi E; Agar JN; Hong Y; Taylor DM; Minotti S; Figlewicz DA; Durham HD J Neurochem; 2008 Jun; 105(6):2353-66. PubMed ID: 18315558 [TBL] [Abstract][Full Text] [Related]
2. Focal dysfunction of the proteasome: a pathogenic factor in a mouse model of amyotrophic lateral sclerosis. Kabashi E; Agar JN; Taylor DM; Minotti S; Durham HD J Neurochem; 2004 Jun; 89(6):1325-35. PubMed ID: 15189335 [TBL] [Abstract][Full Text] [Related]
3. Proteasomal inhibition by misfolded mutant superoxide dismutase 1 induces selective motor neuron death in familial amyotrophic lateral sclerosis. Urushitani M; Kurisu J; Tsukita K; Takahashi R J Neurochem; 2002 Dec; 83(5):1030-42. PubMed ID: 12437574 [TBL] [Abstract][Full Text] [Related]
5. Assessing the role of immuno-proteasomes in a mouse model of familial ALS. Puttaparthi K; Van Kaer L; Elliott JL Exp Neurol; 2007 Jul; 206(1):53-8. PubMed ID: 17482163 [TBL] [Abstract][Full Text] [Related]
6. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1. Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261 [TBL] [Abstract][Full Text] [Related]
7. Non-neuronal induction of immunoproteasome subunits in an ALS model: possible mediation by cytokines. Puttaparthi K; Elliott JL Exp Neurol; 2005 Dec; 196(2):441-51. PubMed ID: 16242125 [TBL] [Abstract][Full Text] [Related]
8. Aggregate formation in the spinal cord of mutant SOD1 transgenic mice is reversible and mediated by proteasomes. Puttaparthi K; Wojcik C; Rajendran B; DeMartino GN; Elliott JL J Neurochem; 2003 Nov; 87(4):851-60. PubMed ID: 14622116 [TBL] [Abstract][Full Text] [Related]
9. Accumulation of human SOD1 and ubiquitinated deposits in the spinal cord of SOD1G93A mice during motor neuron disease progression correlates with a decrease of proteasome. Cheroni C; Peviani M; Cascio P; Debiasi S; Monti C; Bendotti C Neurobiol Dis; 2005 Apr; 18(3):509-22. PubMed ID: 15755678 [TBL] [Abstract][Full Text] [Related]
10. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues. Watanabe M; Dykes-Hoberg M; Culotta VC; Price DL; Wong PC; Rothstein JD Neurobiol Dis; 2001 Dec; 8(6):933-41. PubMed ID: 11741389 [TBL] [Abstract][Full Text] [Related]
11. GAB(A) receptors present higher affinity and modified subunit composition in spinal motor neurons from a genetic model of amyotrophic lateral sclerosis. Carunchio I; Mollinari C; Pieri M; Merlo D; Zona C Eur J Neurosci; 2008 Oct; 28(7):1275-85. PubMed ID: 18973555 [TBL] [Abstract][Full Text] [Related]
13. Failure of protein quality control in amyotrophic lateral sclerosis. Kabashi E; Durham HD Biochim Biophys Acta; 2006; 1762(11-12):1038-50. PubMed ID: 16876390 [TBL] [Abstract][Full Text] [Related]
14. Calcium-permeable AMPA receptors promote misfolding of mutant SOD1 protein and development of amyotrophic lateral sclerosis in a transgenic mouse model. Tateno M; Sadakata H; Tanaka M; Itohara S; Shin RM; Miura M; Masuda M; Aosaki T; Urushitani M; Misawa H; Takahashi R Hum Mol Genet; 2004 Oct; 13(19):2183-96. PubMed ID: 15294873 [TBL] [Abstract][Full Text] [Related]
15. Impaired proteasome function in sporadic amyotrophic lateral sclerosis. Kabashi E; Agar JN; Strong MJ; Durham HD Amyotroph Lateral Scler; 2012 Jun; 13(4):367-71. PubMed ID: 22632443 [TBL] [Abstract][Full Text] [Related]
16. CHIP promotes proteasomal degradation of familial ALS-linked mutant SOD1 by ubiquitinating Hsp/Hsc70. Urushitani M; Kurisu J; Tateno M; Hatakeyama S; Nakayama K; Kato S; Takahashi R J Neurochem; 2004 Jul; 90(1):231-44. PubMed ID: 15198682 [TBL] [Abstract][Full Text] [Related]
17. Metallothionein expression is altered in a transgenic murine model of familial amyotrophic lateral sclerosis. Gong YH; Elliott JL Exp Neurol; 2000 Mar; 162(1):27-36. PubMed ID: 10716886 [TBL] [Abstract][Full Text] [Related]
18. Co-chaperone CHIP associates with mutant Cu/Zn-superoxide dismutase proteins linked to familial amyotrophic lateral sclerosis and promotes their degradation by proteasomes. Choi JS; Cho S; Park SG; Park BC; Lee DH Biochem Biophys Res Commun; 2004 Aug; 321(3):574-83. PubMed ID: 15358145 [TBL] [Abstract][Full Text] [Related]
19. Melittin restores proteasome function in an animal model of ALS. Yang EJ; Kim SH; Yang SC; Lee SM; Choi SM J Neuroinflammation; 2011 Jun; 8():69. PubMed ID: 21682930 [TBL] [Abstract][Full Text] [Related]
20. Integrative role of cPLA with COX-2 and the effect of non-steriodal anti-inflammatory drugs in a transgenic mouse model of amyotrophic lateral sclerosis. Kiaei M; Kipiani K; Petri S; Choi DK; Chen J; Calingasan NY; Beal MF J Neurochem; 2005 Apr; 93(2):403-11. PubMed ID: 15816863 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]